EPISODE · Nov 26, 2025 · 5 MIN
Veeva Systems, Inc. $VEEV - The 5-Minute Ticker
from The 5-Minute Ticker – One stock, two friends, five minutes · host Amanda Irwin and Alan Iglesias
Veeva Systems ($VEEV) is the leading SaaS “picks-and-shovels” provider for the life sciences industry, offering specialized CRM and end-to-end data management tools (think Veeva CRM and Veeva Vault) that are deeply embedded in pharma workflows. Founded by ex‑Salesforce exec Peter Gassner, Veeva turned a niche focus into a sticky, subscription-based business with high switching costs and network effects. Its two core suites—Commercial Cloud for sales/marketing and Development Cloud for clinical, regulatory, and quality—make it mission-critical for drugmakers, while expansion into other regulated industries offers upside. The big strengths are the moat, customer stickiness, and fit with an industry that increasingly needs digital tools; the main risks are concentration in life sciences, rising competitive pressure from big horizontals and specialist rivals, and the distraction or execution challenge of new markets. In short: a dominant, well-positioned platform—but one that faces real competitive and sector-specific risks that could test its staying power.This podcast is for informational and educational purposes only. Information may not be complete or accurate. It does not constitute financial, investment, legal, or other professional advice. Always do your own research and consult with a licensed financial advisor.And don't forget, you can suggest the tickers you're interested in at www.the5minuteticker.com.
What this episode covers
Veeva Systems ($VEEV) is the leading SaaS “picks-and-shovels” provider for the life sciences industry, offering specialized CRM and end-to-end data management tools (think Veeva CRM and Veeva Vault) that are deeply embedded in pharma workflows. Founded by ex‑Salesforce exec Peter Gassner, Veeva turned a niche focus into a sticky, subscription-based business with high switching costs and network effects. Its two core suites—Commercial Cloud for sales/marketing and Development Cloud for clinical, regulatory, and quality—make it mission-critical for drugmakers, while expansion into other regulated industries offers upside. The big strengths are the moat, customer stickiness, and fit with an industry that increasingly needs digital tools; the main risks are concentration in life sciences, rising competitive pressure from big horizontals and specialist rivals, and the distraction or execution challenge of new markets. In short: a dominant, well-positioned platform—but one that faces real competitive and sector-specific risks that could test its staying power.This podcast is for informational and educational purposes only. Information may not be complete or accurate. It does not constitute financial, investment, legal, or other professional advice. Always do your own research and consult with a licensed financial advisor.And don't forget, you can suggest the tickers you're interested in at www.the5minuteticker.com.
NOW PLAYING
Veeva Systems, Inc. $VEEV - The 5-Minute Ticker
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m